000 05836cam a2200421Ii 4500
001 96143
003 ES-MaUEC
005 20230102112740.0
006 m o d
007 cr cnu|||unuuu
008 170608s2017 sz ob 001 0 eng d
020 _a3319492152
_q(electronic bk.)
020 _a9783319492155
_q(electronic bk.)
020 _z3319492136
020 _z9783319492131
040 _aN$T
_cN$T
_dN$T
_dGW5XE
_dYDX
_dOCLCF
_dUAB
_dAZU
_dUPM
_dKOS
_dOCLCO
_dEBLCP
_dMERER
_dESU
_dOCLCQ
_dCOO
_dOCLCQ
_dIOG
_dOCLCA
_dES-MaUEC
_bspa
050 4 _aRC862.I53
_b2017 EB
245 0 0 _aPediatric inflammatory bowel disease
_cPetar Mamula, Andrew B. Grossman, Robert N. Baldassano, Judith R. Kelsen, Jonathan E. Markowitz, editors.
250 _aThird edition.
264 1 _aCham, Switzerland
_bSpringer International Publishing
_c2017
300 _a1 recurso en línea
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _atext file
_bPDF
504 _aIncluye referencias bibliográficas e índice
505 0 _aGenetics of Inflammatory Bowel Diseases -- The Intestinal Immune System During Homeostasis and Inflammatory Bowel Disease -- Cytokines and Inflammatory Bowel Disease -- The Gut Microbiota and Inflammatory Bowel Disease -- Immune Dysregulation Associated with Very Early-Onset Inflammatory Bowel Disease -- Epidemiology of Pediatric Inflammatory Bowel Disease -- The Natural History of Crohn Disease in Children -- Natural History of Ulcerative Colitis in Children -- Natural History of Pediatric Indeterminate Colitis -- Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease -- Liver Disease in Pediatric Inflammatory Bowel Disease -- Growth Impairment in Pediatric Inflammatory Bowel Disease -- Inflammatory Bowel Diseases and Skeletal Health -- Puberty and Pediatric-Onset Inflammatory Bowel Disease -- Classification of Inflammatory Bowel Disease in Children -- The History and Physical Exam -- Differential Diagnosis of Inflammatory Bowel Disease -- Laboratory Evaulation of Inflammatory Bowel Disease -- Fecal Biomarkers in Inflammatory Bowel Disease -- Radiologic Evaulation of Pediatric Inflammatory Bowel Disease -- Endoscopy and Inflammatory Bowel Disease -- The Pathology of Chronic Inflammatory Bowel Disease -- Video Capsule Endoscopy in Inflammatory Bowel Disease -- Bone Health in Pediatric Inflammatory Bowel Disease -- 5-Aminosalicylate Therapy -- Antibiotic Therapy -- Nutritional Management of Inflammatory Bowel Disease -- Probiotic Therapy -- Corticosteroids -- 6-Mercaptopurpine Therapy -- Methotrexate -- Infliximab Therapy for Pediatric Crohn Disease and Ulcerative Colitis -- Anti-TNF Biologic Therapies Other Than Infliximab -- Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease -- New Non-anti-TNF Therapies for the Treatment of Inflammatory Bowel Disease -- Medical Treatment of Perianal Crohn's Disease Fistulae -- Treatment of Acute Severe Ulcerative Colitis -- Dietary Therapies for Inflammatory Bowel Disease -- Complementary and Alternative Therapies -- Management of Intraabdominal Complications of Inflammatory Bowel Disease -- Surgical Management of Crohn Disease in Children -- Surgical Treatment of Ulcerative Colitis -- Postoperative Surveillance and Management of Crohn's Disease -- Pouchitis After Ileal Pouch-Anal Anastomosis -- Enteral Feeding Devices and Ostomies -- Clinical Indices for Pediatric Inflammatory Bowel Disease Research -- Clinical Trials (Clinical Perspective) -- Clinical Trials (Industry/Regulatory Perspective) -- Infectious Complications of Pediatric Inflammatory Bowel Disease -- Psychological Aspects of Inflammatory Bowel Disease in Children and Adolescents -- Measurement of Quality of Life in Pediatric Inflammatory BOwel Disease -- Irritable Bowel Syndrome and Functional GI Disorders in Inflammatory Bowel Disease -- Inflammatory Bowel Disease in Pregnancy -- Immunizations in the Child with Inflammatory Bowel Disease -- Malignant Tumors Arising in Inflammatory Bowel Disease -- Quality Improvement in Inflammatory Bowel Disease -- Fostering Self-Management and Patient Activation -- Advocacy for Pediatric Patients with Inflammatory Bowel Disease -- Legislative Advocacy -- Transition from Pediatric to Adult Care.
520 3 _aThe latest edition of this essential text provides a comprehensive overview of the unique pediatric issues of inflammatory bowel disease. Through new and thoroughly revised chapters, the volume features updates regarding pathogenesis, clinic features, and management, with an emphasis on recent understanding of pharmacokinetics and the utilization of cutting edge therapeutic monitoring to maximize efficacy of medical management. The new edition also highlights newer, recently approved drugs, emerging therapies, and the most recent recommendations regarding post-operative management for patients who ultimately require surgery. Written by experts in the field, Pediatric Inflammatory Bowel Disease, Third Edition is a valuable resource for both pediatric and adult gastroenterologists involved in the care of children with inflammatory bowel disease.
650 7 _aEnfermedad inflamatoria intestinal
_2embne
_0(OCoLC)fst00972441
_0
_9160162
700 1 _aBaldassano, Robert N.,
_eeditor literario
700 1 _aGrossman, Andrew B.,
_eeditor literario
700 1 _aKelsen, Judith R.,
_eeditor literario
700 1 _aMamula, Petar,
_eeditor literario
700 1 _aMarkowitz, Jonathan E.,
_eeditor literario
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-49215-5
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
988 _aSpringer_Medicine_2017
998 _b02/2018
_dz
_e-
_zSI
999 _c96143
_d96143
_x1